Form 8-K - Current report:
SEC Accession No. 0001193125-17-007393
Filing Date
2017-01-11
Accepted
2017-01-11 06:09:07
Documents
12
Period of Report
2017-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d316863d8k.htm 8-K 57951
2 EX-2.1 d316863dex21.htm EX-2.1 437648
3 EX-99.1 d316863dex991.htm EX-99.1 18451
4 EX-99.2 d316863dex992.htm EX-99.2 11576
5 GRAPHIC g316863ex99_2s1g1.jpg GRAPHIC 156605
6 GRAPHIC g316863ex99_2s2g1.jpg GRAPHIC 481421
7 GRAPHIC g316863ex99_2s3g1.jpg GRAPHIC 251152
8 GRAPHIC g316863ex99_2s4g1.jpg GRAPHIC 320109
9 GRAPHIC g316863ex99_2s5g1.jpg GRAPHIC 241359
10 GRAPHIC g316863ex99_2s6g1.jpg GRAPHIC 245575
11 GRAPHIC g316863ex99_2s7g1.jpg GRAPHIC 205785
12 GRAPHIC g316863snap0030.jpg GRAPHIC 3578
  Complete submission text file 0001193125-17-007393.txt   3152547
Mailing Address 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536
Business Address 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 17521937
SIC: 3826 Laboratory Analytical Instruments